Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引:0
|
作者
Muddu, V. [1 ]
Shah, A. [2 ]
Raj, A. [3 ]
Bahl, A. [4 ]
Thirumalairaj, R. [5 ]
Ghosh, J. [6 ]
Ostwal, V. [2 ]
Rajappa, S. [7 ]
Vora, A. [8 ]
Lavingia, V. [9 ]
Sharma, A. [10 ]
Khan, A. [1 ]
Rohatgi, N. [4 ]
Mahajan, M. [11 ]
Chandrakanth, M. [6 ]
Ramaswamy, A. [12 ]
机构
[1] AIG Hosp, Hyderabad, India
[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India
[3] Sarvodaya Hosp, Faridabad, India
[4] Fortis Canc Inst, Gurgaon, India
[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India
[6] Tata Med Ctr, Kolkata, India
[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India
[8] HOPE Oncol Care Clin, New Delhi, India
[9] HCG Canc Ctr, Ahmadabad, Gujarat, India
[10] All India Inst Med Sci, New Delhi, India
[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India
[12] Tata Mem Hosp, Mumbai, Maharashtra, India
关键词
D O I
10.1016/j.annonc.2023.04.265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-209
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 50 条
  • [21] Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study
    Rimini, Margherita
    Masi, Gianluca
    Lonardi, Sara
    Pressiani, Tiziana
    Lavacchi, Daniele
    Nichetti, Federico
    Jessica, Lucchetti
    Giordano, Guido
    Scartozzi, Mario
    Tamburini, Emiliano
    Pastorino, Alessandro
    Rapposelli, Ilario Giovanni
    Daniele, Bruno
    Martinelli, Erika
    Garajova, Ingrid
    Aprile, Giuseppe
    Schirripa, Marta
    Formica, Vincenzo
    Salani, Francesca
    Winchler, Costanza
    Bergamo, Francesca
    Balsano, Rita
    Gusmaroli, Eleonora
    Lorenzo, Angotti
    Landriscina, Matteo
    Pretta, Andrea
    Toma, Ilaria
    Pirrone, Chiara
    Diana, Anna
    Leone, Francesco
    Brunetti, Oronzo
    Brandi, Giovanni
    Garattini, Silvio Ken
    Satolli, Maria Antonietta
    Rossari, Federico
    Fornaro, Lorenzo
    Niger, Monica
    Zanuso, Valentina
    De Rosa, Antonio
    Ratti, Francesca
    Aldrighetti, Luca
    De Braud, Filippo
    Foti, Silvia
    Rizzato, Mario Domenico
    Vivaldi, Caterina
    Stefano, Cascinu
    Rimassa, Lorenza
    Antonuzzo, Lorenzo
    Casadei-Gardini, Andrea
    TARGETED ONCOLOGY, 2024, 19 (3) : 359 - 370
  • [22] A global comparative study on real-world clinical and genomic differences in advanced biliary tract cancer
    Abidoye, Oluseyi
    Hoyek, Celine
    Zheng-Lin, Binbin
    Kosiorek, Heidi E.
    Eslinger, Cody
    Sonbol, Mohamad Bassam
    Wu, Christina
    Tran, Nguyen H.
    Babiker, Hani M.
    Yoshino, Takayuki
    Ikeda, Masafumi
    Morizane, Chigusa
    Bando, Hideaki
    Nakamura, Yoshiaki
    Fujisawa, Takao
    Shibuki, Taro
    Ahn, Daniel H.
    Roberts, Lewis R.
    Borad, Mitesh J.
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 628 - 628
  • [23] Second-line chemotherapy (2L) in elderly patients with advanced biliary tract cancer (ABC): A multicenter real-world study.
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Ricci, Angela Dalia
    Palloni, Andrea
    Messina, Carlo
    Spallanzani, Andrea
    Saccoccio, Gioconda
    Mollica, Veronica
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [24] Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution
    Rimini, Margherita
    Foti, Silvia
    Camera, Silvia
    Rossari, Federico
    Vitiello, Francesco
    Lo Prinzi, Federica
    Aldrighetti, Luca
    De Cobelli, Francesco
    Pedica, Federica
    Arcidiacono, Paolo Giorgio
    Persano, Mara
    Cascinu, Stefano
    Casadei-Gardini, Andrea
    ONCOLOGY, 2024,
  • [25] Real-world treatment patterns, resource utilization and costs in biliary tract cancers in the USA
    Wang, Liya
    Singhal, Mukul
    Valderrama, Adriana
    Nepal, Bal
    Kamble, Shital
    Eluri, Madhulika
    Malhotra, Usha
    Siegel, Abby
    Grabner, Michael
    Swami, Shilpi
    Javle, Milind
    FUTURE ONCOLOGY, 2024,
  • [26] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsieh, Chia-Hsun
    Chang, John Wen-Cheng
    Lin, Cheng-Yu
    Yeh, Chun-Nan
    Chen, Jen-Shi
    BMC CANCER, 2020, 20 (01)
  • [27] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Chiao-En Wu
    Wen-Chi Chou
    Chia-Hsun Hsieh
    John Wen-Cheng Chang
    Cheng-Yu Lin
    Chun-Nan Yeh
    Jen-Shi Chen
    BMC Cancer, 20
  • [28] Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers A Multicenter Retrospective Population-based Cohort Study
    Zaidi, Adnan
    Chandna, Nicholas
    Narasimhan, Gopinath
    Moser, Michael
    Haider, Kamal
    Chalchal, Haji
    Shaw, John
    Ahmed, Shahid
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (03): : 93 - 98
  • [29] Durvalumab Monotherapy in Complex Advanced Hepatocellular Carcinoma: A Real-World Study of Patients Ineligible for Combination Immunotherapy
    Miwa, Chihiro
    Ogasawara, Sadahisa
    Yonemoto, Takuya
    Yumita, Sae
    Okubo, Tomomi
    Nakagawa, Miyuki
    Koroki, Keisuke
    Inoue, Masanori
    Kanogawa, Naoya
    Nakamura, Masato
    Kondo, Takayuki
    Nakamoto, Shingo
    Itokawa, Norio
    Atsukawa, Masanori
    Itobayashi, Ei
    Kato, Naoya
    CANCER MEDICINE, 2025, 14 (05):
  • [30] Systemic chemotherapy for advanced biliary tract cancers: present and future
    Malka, D.
    Boige, V.
    Ducreux, M.
    ONCOLOGIE, 2010, 12 (10) : 623 - 628